NZX-listed seedling business ArborGen has decided against a listing in the United States, its primary market, concluding a strategic review which saw the sale of its New Zealand operations.
The strategic review, handled by PwC, was launched in June last year after the US-headquartered company said
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
